Your browser doesn't support javascript.
loading
Cardiovascular disease risk in patients with inflammatory arthritis nowadays still substantially elevated.
Raadsen, Reinder; Hansildaar, Romy; Pouw, Lianne C; Hooijberg, Femke; Boekel, Laura; Wolbink, Gerrit Jan; van Kuijk, Arno W R; Nurmohamed, Michael T.
Afiliação
  • Raadsen R; Amsterdam Rheumatology and Immunology Center, Amsterdam, Noord-Holland, The Netherlands.
  • Hansildaar R; Amsterdam Rheumatology and Immunology Center, Amsterdam, Noord-Holland, The Netherlands.
  • Pouw LC; Vrije Universiteit Amsterdam Faculteit der Betawetenschappen, Amsterdam, Noord-Holland, The Netherlands.
  • Hooijberg F; Amsterdam Rheumatology and Immunology Center, Amsterdam, Noord-Holland, The Netherlands.
  • Boekel L; Amsterdam Rheumatology and Immunology Center, Amsterdam, Noord-Holland, The Netherlands.
  • Wolbink GJ; Amsterdam Rheumatology and Immunology Center, Amsterdam, Noord-Holland, The Netherlands.
  • van Kuijk AWR; Amsterdam Rheumatology and Immunology Center, Amsterdam, Noord-Holland, The Netherlands.
  • Nurmohamed MT; Amsterdam Rheumatology and Immunology Center, Amsterdam, Noord-Holland, The Netherlands m.nurmohamed@reade.nl.
RMD Open ; 9(4)2023 12 01.
Article em En | MEDLINE | ID: mdl-38053460
ABSTRACT

OBJECTIVES:

This study aims to assess current cardiovascular disease risk and prevalence of risk factors in patients with rheumatoid arthritis (RA), psoriatic arthritis (PsA) and axial spondyloarthritis (SpA).

METHODS:

2050 consecutive patients with inflammatory arthritis (IA) and 939 controls were included, with 1308 patients with RA, 356 patients with PsA and 386 patients with SpA. In a prospective cohort setting, questionnaires regarding previous cardiovascular events and risk factors were used to assess cardiovascular risk and prevalence in patients with IA by calculating ORs using logistic regression models.

RESULTS:

'Traditional' cardiovascular (CV) risk factors were significantly elevated in patients with IA compared with controls. Cardiovascular disease (CVD) ORs were increased in patients with RA and PsA compared with controls, 1.61 (95% CI 1.04 to 2.48) and 2.12 (95% CI 1.23 to 3.66), respectively, and a trend towards increased odds was observed in patients with SpA (OR 1.43; 95% CI 0.79 to 2.59). After adjusting for traditional risk factors, CV risk was not increased in patients with RA (OR; 0.95, 95% CI 0.58 to 1.55), PsA (OR 1.19; 95% CI 0.64 to 2.22) and SpA (OR; 0.91, 95% CI 0.47 to 1.77).

CONCLUSION:

CVD is currently still more prevalent in patients with IA compared with healthy controls and, more importantly, this elevated risk is highly influenced by an increased prevalence of 'traditional' CV risk factors. More attention to, as well as improvements in, identification and treatment of 'traditional' risk factors, need to be made for not only RA, but other IA conditions as well.
Assuntos
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Artrite Reumatoide / Doenças Cardiovasculares / Artrite Psoriásica Limite: Humans Idioma: En Revista: RMD Open Ano de publicação: 2023 Tipo de documento: Article País de afiliação: Holanda

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Artrite Reumatoide / Doenças Cardiovasculares / Artrite Psoriásica Limite: Humans Idioma: En Revista: RMD Open Ano de publicação: 2023 Tipo de documento: Article País de afiliação: Holanda